He has sold over 200 000 shares that is almost half his holdings. I would love to know why but it certainly does not look good for a co-founder of the drug to be selling mid-trial.
He has left heaton and brown life sciences (well I am assuming that is the case form this article) and is now working for Cure JM as Chief Scientific Officer, as I posted back in March.
http://www.curejm.org/news/pr.php
Why he needs the money is anyone guess, but suffice to say Brown is not selling and still heading up H&B life science as far as I can tell (something I pointed out back in march as well for my aggressive little friend apple foot) , so would should he sell. Who knows?. I just wish he sell in a block rather than this constant drip feed.
I will leave this with the same quote I left in March
"Let me know if any one can find out how our interest in these two are doing."